The evolving role of radiation therapy in the management of malignant melanoma.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Radiation Oncology, Biology, Physics

• Publication date

  2011-07-01

• Fields of study

  Medicine, Physics

• Identifiers
  DOI 10.1016/j.ijrobp.2010.12.071PMID 21489712PMCID PMC3119033
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Improved survival with ipilimumab in patients with metastatic melanoma.

  2010cited by this paper
• Mitigation of hematologic radiation toxicity in mice through pharmacological quiescence induced by CDK4/6 inhibition.

  2010cited by this paper
• Inhibition of mutated, activated BRAF in metastatic melanoma.

  2010cited by this paper
• Decreased Energy Metabolism Extends Life Span in Caenorhabditis elegans Without Reducing Oxidative Damage

  2010cited by this paper
• Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma.

  2010cited by this paper
• Radioprotection: smart games with death.

  2010cited by this paper
• Melanocytes in development and cancer

  2010cited by this paper
• Conditional ablation of Ikkb inhibits melanoma tumor development in mice.

  2010cited by this paper
• Cooperative interactions of PTEN deficiency and RAS activation in melanoma metastasis

  2010cited by this paper
• Gamma knife stereotactic radiosurgery yields good long-term outcomes for low-volume uveal melanomas without intraocular complications.

  2010cited by this paper
• Clinical responses observed with imatinib or sorafenib in melanoma patients expressing mutations in KIT

  2010cited by this paper
• The benefits of adjuvant radiation therapy after therapeutic lymphadenectomy for clinically advanced, high‐risk, lymph node‐metastatic melanoma

  2009cited by this paper
• Final version of 2009 AJCC melanoma staging and classification.

  2009cited by this paper
• Hypofractionated stereotactic radiotherapy and radiosurgery for the treatment of patients with radioresistant brain metastases.

  2009cited by this paper
• Cancer Statistics, 2009

  2009cited by this paper
• Functional impairment of p16(INK4A) due to CDKN2A p.Gly23Asp missense mutation.

  2009cited by this paper
• Adjuvant radiotherapy and regional lymph node field control in melanoma patients after lymphadenectomy: Results of an intergroup randomized trial (ANZMTG 01.02/TROG 02.01).

  2009cited by this paper
• Temozolomide, thalidomide, and whole brain radiation therapy for patients with brain metastasis from metastatic melanoma

  2008cited by this paper
• Radiosensitization of melanoma cells through combined inhibition of protein regulators of cell survival

  2008cited by this paper
• p16INK4a-induced senescence is disabled by melanoma-associated mutations

  2008cited by this paper
• Radiation therapy as primary and adjuvant treatment for local and regional melanoma.

  2008cited by this paper
• Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity

  2008cited by this paper
• Frequent p16-independent inactivation of p14ARF in human melanoma.

  2008cited by this paper
• Population‐based prevalence of CDKN2A and CDK4 mutations in patients with multiple primary melanomas

  2008cited by this paper
• Adjuvant Postoperative Radiotherapy to the Cervical Lymph Nodes in Cutaneous Melanoma: Is There Any Benefit for High-Risk Patients?

  2008cited by this paper
• Toward a molecular classification of melanoma.

  2007cited by this paper
• Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma

  2006cited by this paper
• Dispelling the myths surrounding radiotherapy for treatment of cutaneous melanoma.

  2006cited by this paper
• Combined-modality therapy for patients with regional nodal metastases from melanoma.

  2006cited by this paper
• Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture.

  2006cited by this paper
• Somatic activation of KIT in distinct subtypes of melanoma.

  2006cited by this paper
• SEER Cancer Statistics Review, 1975-2003

  2006cited by this paper
• A prospective phase II study of adjuvant postoperative radiation therapy following nodal surgery in malignant melanoma-Trans Tasman Radiation Oncology Group (TROG) Study 96.06.

  2006cited by this paper
• Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation.

  2006cited by this paper
• Cranial irradiation after surgical excision of brain metastases in melanoma patients

  2006cited by this paper
• Postoperative radiotherapy for primary mucosal melanoma of the head and neck

  2005cited by this paper
• The controversial abscopal effect.

  2005cited by this paper
• A dual role of cyclin E in cell proliferation and apoptosis may provide a target for cancer therapy.

  2004cited by this paper
• Opposing roles of E2Fs in cell proliferation and death

  2004cited by this paper
• A Comparison of Survival Rates for Treatment of Melanoma Metastatic to the Brain

  2004cited by this paper
• Stereotactic radiosurgical treatment in 103 patients for 153 cerebral melanoma metastases.

  2004cited by this paper
• The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.

  2004cited by this paper
• Radiotherapy for cutaneous malignant melanoma: rationale and indications.

  2004cited by this paper
• Initial treatment of melanoma brain metastases using gamma knife radiosurgery

  2004cited by this paper
• The role of postoperative adjuvant radiation therapy in the treatment of mucosal melanomas of the head and neck region.

  2003cited by this paper
• THE COMS RANDOMIZED TRIAL OF IODINE 125 BRACHYTHERAPY FOR CHOROIDAL MELANOMA, III: INITIAL MORTALITY FINDINGS COMS REPORT NO. 18

  2002cited by this paper
• Metastatic melanoma to the brain: prognostic factors after gamma knife radiosurgery.

  2002cited by this paper
• The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.

  2001cited by this paper
• Aberrant regulation and function of wild-type p53 in radioresistant melanoma cells.

  2000cited by this paper
• Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

  1998cited by this paper
• Stereotactic radiosurgery for cerebral metastatic melanoma: factors affecting local disease control and survival.

  1998cited by this paper
• The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma III: local complications and observations following enucleation COMS report no. 11.

  1998cited by this paper
• Increase in radiation sensitivity of human malignant melanoma cells by expression of wild-type p16 gene.

  1997cited by this paper
• Malignant melanoma: the role of radiation therapy revisited.

  1996cited by this paper
• Deficiency of retinoblastoma protein leads to inappropriate S-phase entry, activation of E2F-responsive genes, and apoptosis.

  1995cited by this paper
• Fraction size in external beam radiation therapy in the treatment of melanoma.

  1991cited by this paper
• Regional radiotherapy as adjuvant treatment for head and neck malignant melanoma. Preliminary results.

  1990cited by this paper
• Cancer statistics

  1989cited by this paper
• Clinical radiobiology of malignant melanoma.

  1989cited by this paper
• Malignant melanoma: analysis of dose fractionation in radiation therapy.

  1987cited by this paper
• The role of radiotherapy in recurrent and metastatic malignant melanoma: a clinical radiobiological study.

  1986cited by this paper
• Some factors of importance in the radiation treatment of malignant melanoma.

  1986cited by this paper
• Radiation biology of malignant melanoma.

  1986cited by this paper
• A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma.

  1985cited by this paper
• MANAGEMENT OF HEAD AND NECK CANCER ??? A MULTI-DISCIPLINARY APPROACH

  1984cited by this paper
• Does enucleation of the eye containing a malignant melanoma prevent or accelerate the dissemination of tumour cells.

  1978cited by this paper
• The radiation response of human malignant melanoma cells grown in vitro.

  1971cited by this paper
• X Rays and Radium in the Treatment of Diseases of the Skin

  1967cited by this paper
• RADIATION THERAPY OF PRIMARY AND METASTATIC MELANOMA

  1963cited by this paper
• The Radiosensitivity of Malignant Melanomata

  1939cited by this paper
• MELANOTIC CANCER WITH A REPORT OF 91 CASES

  1916cited by this paper

• Advances in the systemic administration of nanotechnology-mediated drug delivery systems in melanoma treatment: a systematic review

  2025cites this paper
• Sinonasal Mucosal Melanoma: A Comprehensive Review and Clinical Experience

  2025cites this paper
• A rare case of brain metastatic malignant melanoma coexisting with black colored dura mater: Management in low-resource setting

  2025cites this paper
• Proton therapy for primary and recurrent HPV-related oropharyngeal cancer.

  2025cites this paper
• Efficiency of hypofractionated radiotherapy for bone metastases in a female patient with advanced skin melanoma

  2022cites this paper
• 9 Clinical Applications of Radiotherapy for Skull Base Tumors Skull base tumors

  2021cites this paper
• Adjuvant Therapy of Melanoma.

  2021cites this paper
• Melanoma

  2020cites this paper
• HDAC2 Inhibitor Valproic Acid Increases Radiation Sensitivity of Drug-Resistant Melanoma Cells

  2019cites this paper
• Targeted Radionuclide Therapy Decreases Melanoma Lung Invasion by Modifying Epithelial-Mesenchymal Transition-Like Mechanisms

  2019cites this paper
• The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma

  2019cites this paper
• Combining the DNA Repair Inhibitor Dbait With Radiotherapy for the Treatment of High Grade Glioma: Efficacy and Protein Biomarkers of Resistance in Preclinical Models

  2019cites this paper
• Twice-daily Radiation for Metastatic Malignant Melanoma: A Different Approach Resulting in a Significant Response

  2019cites this paper
• A comparison between skin dose of breast cancer patients at the breast region, measured by thermoluminescent dosimeter in the presence and absence of bolus

  2018cites this paper
• Do you know your guidelines? Diagnosis and management of cutaneous head and neck melanoma

  2018cites this paper
• Hodgkin’s lymphoma

  2018cites this paper
• Management of Melanoma Locoregional Recurrence

  2018cites this paper
• Carbon ion irradiation abrogates Lin28B-induced X-ray resistance in melanoma cells

  2017cites this paper
• Cold Atmospheric Plasma, Created at the Tip of an Elongated Flexible Capillary Using Low Electric Current, Can Slow the Progression of Melanoma

  2017cites this paper
• Etude du rôle des fibroblastes associés au mélanome dans la modulation de la réponse immune anti-tumorale : influence de la sécrétion de métalloprotéinases matricielles sur la lyse tumorale dépendante des cellules NK et de l’hypoxie sur leur potentiel immunosuppresseur

  2017cites this paper
• The TLR7 agonist imiquimod induces anti-cancer effects via autophagic cell death and enhances anti-tumoral and systemic immunity during radiotherapy for melanoma

  2017cites this paper
• Ipilimumab and Stereotactic Radiosurgery Versus Stereotactic Radiosurgery Alone for Newly Diagnosed Melanoma Brain Metastases

  2017cites this paper
• Correlations of EGF G1380A, bFGF C754G and VEGF T460C polymorphisms with malignant melanoma susceptibility and prognosis: A case-control study.

  2017cites this paper
• Early imaging radioresponsiveness of melanoma brain metastases as a predictor of patient prognosis.

  2017cites this paper
• Accelerated or conventional whole brain irradiation of malignant melanoma

  2017cites this paper
• Adipocyte Secretome Increases Radioresistance of Malignant Melanocytes by Improving Cell Survival and Decreasing Oxidative Status

  2017cites this paper
• Reirradiation of Head and Neck Cancers With Proton Therapy: Outcomes and Analyses.

  2016cites this paper
• BRAF inhibitors and radiotherapy for melanoma brain metastases: potential advantages and disadvantages of combination therapy

  2016cites this paper
• Comparative Aspects of Canine Melanoma

  2016cites this paper
• Raster‐scanned intensity‐controlled carbon ion therapy for mucosal melanoma of the paranasal sinus

  2016cites this paper
• Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial12

  2016cites this paper
• The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis.

  2016cites this paper
• Radiation response and PI3K/mTOR targeting in canine melanoma

  2016cites this paper
• The influence of postoperative lymph node radiation therapy on overall survival of patients with stage III melanoma, a National Cancer Database analysis

  2016cites this paper
• Etude des effets cytotoxique et antitubuline des imidazoquinoxalines : Etude du mécanisme d’action par une analyse transcriptomique

  2016cites this paper
• Two heads better than one? Ipilimumab immunotherapy and radiation therapy for melanoma brain metastases.

  2015cites this paper
• Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent manner

  2015cites this paper
• IL‐9 inhibits HTB‐72 melanoma cell growth through upregulation of p21 and TRAIL

  2015cites this paper
• Clinical Management ofMultipleMelanoma BrainMetastases A Systematic Review

  2015cites this paper
• Clinical Management of Multiple Melanoma Brain Metastases: A Systematic Review.

  2015cites this paper
• Single‐fraction stereotactic body radiation therapy for sinonasal malignant melanoma

  2015cites this paper
• Enhanced radiosensitization by the cationic liposome-encapsulated thymidine analogue BrdU through the increased intracellular BrdU-uptake on human melanoma as compared to anionic or nonionic liposomal or free BrdU.

  2014cites this paper
• Enhanced antitumor efficacy with combined administration of astragalus and pterostilbene for melanoma.

  2014cites this paper
• RADIATION & YOUR PATIENT

  2014cites this paper
• The role of radiotherapy in the management of sinonasal melanoma and its impact on patients and healthcare professionals

  2014cites this paper
• Rage (Receptor for Advanced Glycation End Products) in Melanoma Progression

  2014cites this paper
• A Preclinical Study Combining the DNA Repair Inhibitor Dbait with Radiotherapy for the Treatment of Melanoma

  2014cites this paper
• Development of DNA Damage Response Signaling Biomarkers using Automated, Quantitative Image Analysis

  2014cites this paper
• Prognostic Factors for Overall Survival After Radiosurgery for Brain Metastases From Melanoma

  2014cites this paper
• CTC1 increases the radioresistance of human melanoma cells by inhibiting telomere shortening and apoptosis

  2014cites this paper
• Efficacy of Different Sequences of Radio‐ and Chemotherapy in Experimental Models of Human Melanoma

  2014cites this paper
• Stereotactic ablative body radiotherapy (SABR) for effective palliation of metastases: factors affecting local control.

  2014cites this paper
• Synergistic cytotoxicity of radiation and oncolytic Lister strain vaccinia in V600D/EBRAF mutant melanoma depends on JNK and TNF-α signaling

  2014cites this paper
• Current Treatment of Locoregional Recurrence of Melanoma

  2013cites this paper
• SLUG silencing increases radiosensitivity of melanoma cells in vitro

  2013cites this paper
• Quantitative proteomic analysis for radiation-induced cell cycle suspension in 921 melanoma cell line

  2013cites this paper
• Long-term stabilization of leptomeningeal disease with whole-brain radiation therapy in a patient with metastatic melanoma treated with vemurafenib: a case report.

  2013cites this paper
• Diagnostic and Therapeutic Approaches in Italian Hospitals: Adjuvant and Metastatic Therapy in Melanoma

  2013cites this paper
• Quantitative proteomic analysis for radiation-induced cell cycle suspension in 92-1 melanoma cell line

  2013cites this paper
• Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part I: Management of stage III disease.

  2013cites this paper
• Management options for metastatic melanoma in the era of novel therapies: a primer for the practicing dermatologist: part II: Management of stage IV disease.

  2013cites this paper
• A potential role for resveratrol as a radiation sensitizer for melanoma treatment.

  2013cites this paper
• Outcomes of primary mucosal melanoma originated from sinonasal tract

  2013cites this paper
• The red journal's top 10 most downloaded articles of 2011.

  2012cites this paper
• Radiation as an immunological adjuvant: current evidence on dose and fractionation

  2012cites this paper
• Management of loco-regionally recurrent melanoma

  2012cites this paper
• Adjuvant Therapy for Resected Stage III Melanoma Patients: High-Dose Interferon-Alpha versus Ipilimumab Combined with Kinases Inhibitors

  2012cites this paper
• Adjuvante Therapie des malignen Melanoms

  2012cites this paper
• Malignant melanoma and radiotherapy: past myths, excellent local control in 146 studied lesions at Georgetown University, and improving future management

  2012cites this paper
• Finally, a substantial role for radiotherapy in melanoma.

  2012cites this paper
• Adjuvant therapy for resected stage III melanoma patients: high-dose interferon-alpha versus ipilimumab combined with kinases inhibitors.

  2012cites this paper
• Expression von SLC-Transportern in Melanomzelllinien und Charakterisierung von MATE1 und OCT1 in ihrer Funktion als Zytostatikatransporter

  2011influential citation